Onconova Therapeutics, Inc

(NASDAQ:ONTX)

Latest On Onconova Therapeutics, Inc (ONTX):

Date/Time Type Description Signal Details
2023-05-16 02:59 ESTNewsOnconova Therapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $0.06M misses by $0.02MN/A
2023-05-16 02:59 ESTNewsOnconova Therapeutics, Inc. (ONTX) Q1 2023 Earnings Call TranscriptN/A
2023-03-23 22:47 ESTNewsOnconova, Pangea team up to find biomarkers for cancer drug rigosertibN/A
2023-03-17 12:25 ESTNewsOnconova Therapeutics, Inc. (ONTX) Q4 2022 Earnings Call TranscriptN/A
2023-03-16 21:37 ESTNewsOnconova Therapeutics GAAP EPS of -$0.91 misses by $0.63, revenue of $0.23M beats by $0.17MN/A
2023-02-07 22:15 ESTNewsOnconova Therapeutics posts positive data from squamous cell carcinoma treatment trialN/A
2022-11-15 05:58 ESTNewsOnconova Therapeutics GAAP EPS of -$0.26 misses by $0.05, revenue of $0.06M misses by $0.01MN/A
2022-11-15 05:57 ESTNewsOnconova Therapeutics, Inc. (ONTX) Q3 2022 Earnings Call TranscriptN/A
2022-11-12 09:08 ESTNewsOnconova Therapeutics Q3 Earnings PreviewN/A
2022-09-12 22:02 ESTNewsOnconova rigosertib/Opdivo combo shows promise in advanced lung cancer in trialN/A
2022-08-12 06:06 ESTNewsOnconova Therapeutics GAAP EPS of -$0.19 beats by $0.01, revenue of $0.06M in-lineN/A
2022-08-12 06:05 ESTNewsOnconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 21:27 ESTNewsOnconova Therapeutics Q2 Earnings PreviewN/A
2022-06-13 10:43 ESTNewsOnconova Therapeutics appoints company's CFO Mark Guerin as the new COON/A
2022-05-12 03:01 ESTNewsOnconova Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $0.06M misses by $0.02MN/A
2022-05-12 03:01 ESTNewsOnconova Therapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 03:01 ESTNewsOnconova Q1 net loss narrows 13% although revenue remains flatN/A
2022-05-12 03:01 ESTNewsOnconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 07:21 ESTNewsOnconova Therapeutics Q1 Earnings PreviewN/A
2022-03-19 03:23 ESTNewsOnconova Therapeutics' (ONTX) CEO Steve Fruchtman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-19 03:22 ESTNewsOnconova Therapeutics shares fall after wider-than-expected FY lossN/A
2022-03-17 17:56 ESTNewsOnconova Therapeutics FY Earnings PreviewN/A
2022-03-17 17:56 ESTNewsOnconova Therapeutics GAAP EPS of -$0.96 misses by $0.04, revenue of $0.23M in-lineN/A
2022-03-11 15:45 ESTNewsOnconova Therapeutics (ONTX) Investor Presentation - SlideshowN/A
2022-02-11 07:14 ESTNewsOnconova Therapeutics (ONTX) Investor Presentation IP - SlideshowN/A
2021-11-13 01:52 ESTNewsOnconova Therapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-12 06:10 ESTNewsOnconova Therapeutics EPS beats by $0.11, beats on revenueN/A
2021-11-12 06:09 ESTNewsOnconova Therapeutics, Inc.'s (ONTX) CEO Steve Fruchtman on Q3 2021 Earning Conference Call - Earnings Call TranscriptN/A
2021-11-11 10:44 ESTNewsOnconova Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-12 10:49 ESTNewsWarning: ONTX is at high risk of performing badlyN/A
2021-10-06 14:08 ESTNewsONTX is at high risk of performing badlyN/A
2021-09-28 21:49 ESTNewsOnconova Therapeutics closes $21M equity offeringN/A
2021-09-27 23:09 ESTNewsWarning: ONTX has been downgraded to Very BearishN/A
2021-09-24 10:36 ESTNewsOnconova Therapeutics shares fall on proposed capital raiseN/A
2021-09-24 10:36 ESTNewsOnconova Therapeutics shares drop 14% on $21M capital raiseN/A
2021-09-23 08:54 ESTNewsOnconova stock jumps 27% on encouraging rigosertib-nivolumab combo data in KRAS+ lung cancerN/A
2021-09-22 02:31 ESTNewsWarning: ONTX has been downgraded to Very Bearish.N/A
2021-08-16 22:33 ESTNewsOnconova Therapeutics, Inc.'s (ONTX) CEO Steve Fruchtman on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-12 22:02 ESTNewsOnconova Therapeutics EPS beats by $0.01, beats on revenueN/A
2021-08-12 22:02 ESTNewsOnconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 18:16 ESTNewsOnconova Therapeutics names Mark Gelder as chief medical officerN/A
2021-07-21 18:07 ESTNewsOnconova Therapeutics surges 17% but still in negative territory year to dateN/A
2021-07-21 17:59 ESTNewsOnconova Therapeutics regains Nasdaq continued listing complianceN/A
2021-07-21 17:57 ESTNewsPreliminary early-stage results encouraging for Onconova NSCLC candidateN/A
2021-04-22 20:02 ESTNewsOnconova announces dosing of first patient in mid-stage skin cancer studyN/A
2021-04-01 21:01 ESTNewsEnrollment underway in Onconova's early-stage study of ON 123300 in ChinaN/A
2021-03-16 21:39 ESTEarnings EstimateAn EPS average of -$0.03 is estimated for the quarter ending on March 31, 2021.N/A
2021-03-16 21:39 ESTEarnings EstimateAn EPS average of -$0.03 is estimated for the quarter ending on June 30, 2021.N/A
2021-03-14 05:14 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 08:35 ESTNewsOnconova Therapeutics EPS in-line, beats on revenueN/A

About Onconova Therapeutics, Inc (ONTX):

Onconova Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and a dose-escalation and expansion Phase 1 trial is planned in the U.S. The company's product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. In addition, it is involved in preclinical work investigating rigosertib in COVID-19. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.

ONTX Quotes by TradingView

See Advanced Chart

General

  • Name Onconova Therapeutics, Inc
  • Symbol ONTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:15
  • Last Split Date2018-09-26
  • Fiscal Year EndDecember
  • IPO Date2013-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.onconova.com
View More

Valuation

  • Trailing PE 0.83
  • Price/Sales (Trailing 12 Mt.) 843.21
  • Price/Book (Most Recent Quarter) 24.21
  • Enterprise Value Revenue 1331.21
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.10
  • Next Year EPS Estimate -$0.12
  • Operating Margin -10819%
  • Return on Assets -72%
  • Return on Equity -283%
  • Revenue 231000
  • Earnings Per Share -$3.81
  • Revenue Per Share $0
  • Gross Profit 231000
  • Quarterly Earnings Growth 90%
View More

Highlights

  • Market Capitalization 265.01 million
  • EBITDA -20981000
  • Analyst Target Price $2.1
  • Book Value Per Share $0.03
View More

Share Statistics

  • Shares Outstanding 236.61 million
  • Shares Float 173.72 million
  • % Held by Insiders 56%
  • % Held by Institutions 11.21%
  • Shares Short 18.24 million
  • Shares Short Prior Month 16.35 million
  • Short Ratio 0.21
  • Short % of Float 8%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.91
  • 52 Week High $1.87
  • 52 Week Low $0.19
  • 50 Day Moving Average 1.13
  • 200 Day Moving Average 0.56
View More

Dividends

  • Dividend Date 2018-09-26
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Onconova Therapeutics, Inc (ONTX) Dividend Calendar:

ONTX's last dividend payment was made to shareholders on September 26, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Onconova Therapeutics, Inc (ONTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.03-$0.0414.29%
2020-09-302020-11-12$66000-$0.03-$0.039.91%
2020-06-302020-08-12$56000-$0.04-$0.03-33.33%
2020-03-312020-05-14$52000-$0.03-$0.0645.45%
2019-12-312020-03-24$30000-$0.40-$0.25-60%
2019-09-302019-11-12$63000-$0.75-$0.68-10.29%
2019-06-302019-08-14$2.02 million-$0.60-$0.8831.82%
2019-03-312019-05-14$68000-$1.29-$1.04-24.64%
2018-12-312019-03-26$59000-$0.85-$0.9712.14%
2018-09-302018-11-13$120000-$0.94-$1.1618.97%
2018-06-302018-08-14$485000-$1.05-$1.158.7%
2018-03-312018-05-15$564000-$5.10-$5.9013.56%
2017-12-312018-03-08$143000-$8.85-$10.3114.18%
2017-09-302017-11-09$110000-$10.65-$10.39-2.53%
2017-06-302017-08-14$324000-$4.35-$10.8559.91%
2017-03-312017-05-15$210000-$18.45-$14.40-28.13%
2016-12-312017-03-27$173000-$8.10-$15.0046%
2016-09-302016-11-14$1.65 million-$4.35-$12.3064.63%
2016-06-302016-08-15$2.25 million-$29.40-$44.4033.78%
2016-03-312016-05-11$1.47 million-$41.25-$28.50-44.72%
2015-12-312016-03-28$9.6 million$27.00-$40.50166.67%
2015-09-302015-11-11$1.62 million-$2.60-$3.2319.5%
2015-06-302015-08-13$123000-$4.10-$5.5726.39%
2015-03-312015-05-14$114000-$5.70-$6.309.52%
2014-12-312015-03-26$114000-$6.20-$6.271.12%
2014-09-302014-11-13$114000-$6.90-$7.477.63%
2014-06-302014-08-13$125000-$115.50-$130.5011.49%
2014-03-312014-05-12$447000-$130.50-$110.62-17.97%
2013-12-312014-03-10$1.93 million-$102.00-$160.5036.45%
2013-09-302013-11-12$1.12 million-$201.00-$97.87-105.37%
2013-06-302013-09-06$591000-$781.42

Onconova Therapeutics, Inc (ONTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A 4.19 million 4.8 million 3.37 million 4.05 million
Income Before Tax N/A -6.24 million -7.4 million -5.09 million -5.74 million
Selling General Administrative N/A 2.15 million 2.59 million 1.81 million 3.31 million
Gross Profit N/A N/A N/A N/A 30000
Ebit N/A -6.27 million -7.34 million -5.12 million -7.33 million
Operating Income N/A -6.27 million -7.34 million -5.13 million -7.33 million
Income Tax Expense 4000 N/A N/A N/A 10000
Total Revenue N/A 66000 56000 52000 30000
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A 33000 -56000 33000 1.59 million
Net Income From Continuing Operations N/A -6.24 million -7.4 million -5.09 million -5.75 million
Net Income Applicable to Common Shares -6.43 million -6.24 million -7.4 million N/A -5.75 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A -15000 N/A N/A N/A
Change to Liabilities N/A 909000 N/A N/A -283000
Total Cash Flow from Investing Activities N/A -15000 N/A N/A -56000
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A 1.58 million 14.78 million N/A 2.97 million
Change to Operating Activities N/A 951000 N/A N/A -447000
Change in Cash N/A -3.81 million 8.31 million N/A -1.06 million
Total Cash from Operating Activities N/A -5.38 million -6.46 million N/A -3.96 million
Depreciation N/A 2000 3000 N/A 3000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A 1.69 million
Other Cash Flow from Financing Activities N/A -2000 N/A N/A N/A
Change to Net Income N/A 148000 N/A N/A -330000
Capital Expenditures N/A N/A N/A N/A 56000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A 12.57 million 10.73 million 12.1 million
Total Stockholder Equity N/A N/A 15.63 million 21.35 million 11.57 million
Other Current Liabilities 226000 226000 N/A N/A 226000
Total Assets N/A N/A 28.2 million 32.07 million 23.67 million
Common Stock 1.86 million 1.85 million 1.74 million N/A 1.11 million
Other Current Assets N/A N/A 312000 222000 N/A
Retained Earnings -428.56 million -422.13 million -415.89 million -408.49 million -403.4 million
Other Liabilities 3.79 million 3.7 million 3.82 million N/A 3.81 million
Other Assets 150000 150000 150000 N/A 150000
Cash N/A N/A 27.23 million 31.04 million 22.73 million
Total Current Liabilities 10.02 million 9.29 million 8.75 million 6.91 million 8.29 million
Other Stockholder Equity 14000 -2000 -17000 N/A -18000
Property, Plant & Equipment 52000 56000 60000 N/A 50000
Total Current Assets 19.78 million 25 million 27.99 million 31.88 million 23.47 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 6.18 million 12.22 million 15.63 million N/A 11.57 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.83 million 5.73 million 5.15 million 4.18 million 4.27 million

Onconova Therapeutics, Inc (ONTX) Chart:

Onconova Therapeutics, Inc (ONTX) News:

Below you will find a list of latest news for Onconova Therapeutics, Inc (ONTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Onconova Therapeutics, Inc (ONTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 00TRUE00
2024-05-1750CALL0 00TRUE00
2024-05-177.50CALL0 00TRUE00
2024-05-172.50PUT0 0337.67FALSE00
2024-05-1750PUT0 0667.97FALSE00
2024-05-177.50PUT0 0537.86FALSE00
2024-07-192.50.1CALL6 1470TRUE00
2024-07-1950CALL0 00TRUE00
2024-07-197.50CALL0 00TRUE00
2024-07-192.50PUT0 0211.28FALSE00
2024-07-1950PUT0 0567.32FALSE00
2024-07-197.50PUT0 0361.32FALSE00
2024-10-182.50.1CALL3 42117.67TRUE00
2024-10-1850CALL0 00TRUE00
2024-10-187.50.1CALL0 10TRUE00
2024-10-182.50PUT0 0179.06FALSE00
2024-10-1850PUT0 0435.74FALSE00
2024-10-187.50PUT0 0374.14FALSE00

Latest ONTX Trades:

Date Shares Price
Jun 13, 2022 2:34 PM EST400$1.2
Jun 13, 2022 2:57 PM EST200$1.16
Jun 13, 2022 3:52 PM EST100$1.17
Jun 13, 2022 7:59 PM EST37$1.17

Onconova Therapeutics, Inc (ONTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920080640/0001104659-20-080640-index.htm
2019-04-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1130598/000000000019007001/0000000000-19-007001-index.htm
2019-11-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1130598/000000000019015338/0000000000-19-015338-index.htm
2020-05-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1130598/000000000020004003/0000000000-20-004003-index.htm
2019-11-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000089914019000626/0000899140-19-000626-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000089914020000166/0000899140-20-000166-index.htm
2019-02-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000248/0000905718-19-000248-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000557/0000905718-19-000557-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000579/0000905718-19-000579-index.htm
2019-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000596/0000905718-19-000596-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000753/0000905718-19-000753-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000773/0000905718-19-000773-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000775/0000905718-19-000775-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000781/0000905718-19-000781-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000785/0000905718-19-000785-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000789/0000905718-19-000789-index.htm
2019-11-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000090571819000947/0000905718-19-000947-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000090571820000249/0000905718-20-000249-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000091957419001736/0000919574-19-001736-index.htm
2019-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000091957419006022/0000919574-19-006022-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000091957419006024/0000919574-19-006024-index.htm
2019-09-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000091957419006026/0000919574-19-006026-index.htm
2019-12-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000091957419007734/0000919574-19-007734-index.htm
2020-01-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000091957420000305/0000919574-20-000305-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000093583619000129/0000935836-19-000129-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000093583620000138/0000935836-20-000138-index.htm
2019-09-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1130598/000101359419000537/0001013594-19-000537-index.htm
2020-02-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1130598/000101359420000187/0001013594-20-000187-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1130598/000104746919001839/0001047469-19-001839-index.htm
2019-04-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000104746919002017/0001047469-19-002017-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1130598/000104746919002692/0001047469-19-002692-index.htm
2019-05-17S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000104746919003190/0001047469-19-003190-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1130598/000104746920001878/0001047469-20-001878-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1130598/000104746920002532/0001047469-20-002532-index.htm
2018-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465918048146/0001104659-18-048146-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465918051777/0001104659-18-051777-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465918052015/0001104659-18-052015-index.htm
2018-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/0001104659-18-054173-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465918058465/0001104659-18-058465-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465918061975/0001104659-18-061975-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465918067744/0001104659-18-067744-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465918068490/0001104659-18-068490-index.htm
2019-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919001965/0001104659-19-001965-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919017274/0001104659-19-017274-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919029130/0001104659-19-029130-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919029745/0001104659-19-029745-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919029989/0001104659-19-029989-index.htm
2019-05-17424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919030300/0001104659-19-030300-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919030304/0001104659-19-030304-index.htm
2019-05-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919030327/0001104659-19-030327-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919031827/0001104659-19-031827-index.htm
2019-06-04DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000110465919033519/0001104659-19-033519-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919036364/0001104659-19-036364-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919042316/0001104659-19-042316-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919045789/0001104659-19-045789-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919045963/0001104659-19-045963-index.htm
2019-08-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1130598/000110465919046971/0001104659-19-046971-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919050125/0001104659-19-050125-index.htm
2019-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919050126/0001104659-19-050126-index.htm
2019-09-13FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1130598/000110465919050158/0001104659-19-050158-index.htm
2019-09-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919050424/0001104659-19-050424-index.htm
2019-09-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919051265/0001104659-19-051265-index.htm
2019-09-25424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919051266/0001104659-19-051266-index.htm
2019-09-25424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919051268/0001104659-19-051268-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919051271/0001104659-19-051271-index.htm
2019-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919055985/0001104659-19-055985-index.htm
2019-10-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000110465919057049/0001104659-19-057049-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919062715/0001104659-19-062715-index.htm
2019-11-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919062751/0001104659-19-062751-index.htm
2019-11-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000110465919062752/0001104659-19-062752-index.htm
2019-11-14S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000110465919063513/0001104659-19-063513-index.htm
2019-11-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919063516/0001104659-19-063516-index.htm
2019-11-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919063519/0001104659-19-063519-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919065505/0001104659-19-065505-index.htm
2019-11-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919065693/0001104659-19-065693-index.htm
2019-11-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919065694/0001104659-19-065694-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919066039/0001104659-19-066039-index.htm
2019-11-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000110465919066050/0001104659-19-066050-index.htm
2019-11-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919066093/0001104659-19-066093-index.htm
2019-11-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465919066094/0001104659-19-066094-index.htm
2019-11-25424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919066848/0001104659-19-066848-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919066850/0001104659-19-066850-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919067235/0001104659-19-067235-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919070579/0001104659-19-070579-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919070818/0001104659-19-070818-index.htm
2019-12-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919071186/0001104659-19-071186-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919071255/0001104659-19-071255-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919074102/0001104659-19-074102-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919074106/0001104659-19-074106-index.htm
2019-12-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1130598/000110465919074107/0001104659-19-074107-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465919074375/0001104659-19-074375-index.htm
2020-01-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1130598/000110465920000587/0001104659-20-000587-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920000994/0001104659-20-000994-index.htm
2020-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920005195/0001104659-20-005195-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920006085/0001104659-20-006085-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920037758/0001104659-20-037758-index.htm
2020-04-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1130598/000110465920045239/0001104659-20-045239-index.htm
2020-04-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000110465920051099/0001104659-20-051099-index.htm
2020-05-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1130598/000110465920059137/0001104659-20-059137-index.htm
2020-05-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1130598/000110465920059138/0001104659-20-059138-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920061646/0001104659-20-061646-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465920062608/0001104659-20-062608-index.htm
2020-05-15S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1130598/000110465920062699/0001104659-20-062699-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465920062705/0001104659-20-062705-index.htm
2020-05-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1130598/000110465920062708/0001104659-20-062708-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920069042/0001104659-20-069042-index.htm
2020-06-02DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1130598/000110465920069045/0001104659-20-069045-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920072086/0001104659-20-072086-index.htm
2020-06-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1130598/000110465920072088/0001104659-20-072088-index.htm
2020-06-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1130598/000110465920072999/0001104659-20-072999-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920080640/0001104659-20-080640-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920082789/0001104659-20-082789-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920089955/0001104659-20-089955-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920093895/0001104659-20-093895-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1130598/000110465920093990/0001104659-20-093990-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920097780/0001104659-20-097780-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920100480/0001104659-20-100480-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000110465920113957/0001104659-20-113957-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010007/0001179110-18-010007-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010008/0001179110-18-010008-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010009/0001179110-18-010009-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010010/0001179110-18-010010-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010011/0001179110-18-010011-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010012/0001179110-18-010012-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010013/0001179110-18-010013-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010014/0001179110-18-010014-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010015/0001179110-18-010015-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018010016/0001179110-18-010016-index.htm
2018-11-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018012640/0001179110-18-012640-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018012642/0001179110-18-012642-index.htm
2018-12-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911018013906/0001179110-18-013906-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019004834/0001179110-19-004834-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019008865/0001179110-19-008865-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019008866/0001179110-19-008866-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019008867/0001179110-19-008867-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019008868/0001179110-19-008868-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019008869/0001179110-19-008869-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019008871/0001179110-19-008871-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019010682/0001179110-19-010682-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019012054/0001179110-19-012054-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019012056/0001179110-19-012056-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019012057/0001179110-19-012057-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019012058/0001179110-19-012058-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019012059/0001179110-19-012059-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019012105/0001179110-19-012105-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019013137/0001179110-19-013137-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019013138/0001179110-19-013138-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019013139/0001179110-19-013139-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019013140/0001179110-19-013140-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911019013141/0001179110-19-013141-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020006357/0001179110-20-006357-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020006358/0001179110-20-006358-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020006359/0001179110-20-006359-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020006452/0001179110-20-006452-index.htm
2020-06-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020007084/0001179110-20-007084-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008191/0001179110-20-008191-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008193/0001179110-20-008193-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008195/0001179110-20-008195-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008198/0001179110-20-008198-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008202/0001179110-20-008202-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008207/0001179110-20-008207-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008208/0001179110-20-008208-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008209/0001179110-20-008209-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008210/0001179110-20-008210-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008211/0001179110-20-008211-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008212/0001179110-20-008212-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020008213/0001179110-20-008213-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020009437/0001179110-20-009437-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000117911020009439/0001179110-20-009439-index.htm
2019-12-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000121390019025140/0001213900-19-025140-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1130598/000141057818000570/0001410578-18-000570-index.htm
2019-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000153561019000008/0001535610-19-000008-index.htm
2019-09-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000153561019000097/0001535610-19-000097-index.htm
2020-01-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1130598/000153561020000032/0001535610-20-000032-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1130598/000156761919018586/0001567619-19-018586-index.htm
2019-05-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1130598/999999999519001161/9999999995-19-001161-index.htm
2019-11-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1130598/999999999519002636/9999999995-19-002636-index.htm
2020-05-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1130598/999999999520001187/9999999995-20-001187-index.htm
2020-02-07SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1130598/999999999720000598/9999999997-20-000598-index.htm
2020-02-19SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1130598/999999999720000804/9999999997-20-000804-index.htm

Onconova Therapeutics, Inc (ONTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Onconova Therapeutics, Inc (ONTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 56%
Institutional Ownership: 1121%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-27Michael B HoffmanDirectorSell1,876.000.27510.080.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020009437/0001179110-20-009437-index.htm
2020-05-19JEROME GROOPMANDirectorBuy10,000.000.363,626.0010,001.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020006452/0001179110-20-006452-index.htm
2020-05-19Mark Patrick GuerinChief Financial OfficerBuy21,000.000.367,560.00108,844.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020006358/0001179110-20-006358-index.htm
2019-11-25Steven M FruchtmanPresident, Chief Executive OffBuy149,000.000.2029,800.00149,426.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019012057/0001179110-19-012057-index.htm
2020-08-27E Premkumar ReddyDirectorSell527,863.000.27143,948.2416,683.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020009439/0001179110-20-009439-index.htm
2019-11-25JAMES J MARINODirectorBuy150,000.000.2030,000.00166,942.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019012058/0001179110-19-012058-index.htm
2019-09-25JAMES J MARINODirectorBuy7,260.001.6011,616.0016,942.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019010682/0001179110-19-010682-index.htm
2020-05-19Steven M FruchtmanPresident, Chief Executive OffBuy26,800.000.379,857.04176,226.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020006357/0001179110-20-006357-index.htm
2020-08-27Michael B HoffmanDirectorSell182,492.000.2749,619.5721,919.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020009437/0001179110-20-009437-index.htm
2019-11-25VIREN MEHTADirectorBuy250,000.000.2050,000.00250,857.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019012105/0001179110-19-012105-index.htm
2019-09-18683 Capital Management, LLCInsiderSell1,533.002.203,375.97460,000.00https://www.sec.gov/Archives/edgar/data/1130598/000156761919018586/0001567619-19-018586-index.htm
2019-09-18683 Capital Management, LLCInsiderSell120,000.001.82218,184.00461,533.00https://www.sec.gov/Archives/edgar/data/1130598/000156761919018586/0001567619-19-018586-index.htm
2019-11-25E Premkumar ReddyDirectorBuy500,000.000.20100,000.00544,546.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019012059/0001179110-19-012059-index.htm
2018-08-29Michael B HoffmanDirectorSell29,999.260.4513,520.675,731,116.73https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/0001104659-18-054173-index.htm
2018-08-28Michael B HoffmanDirectorSell30,000.000.4613,707.005,761,116.00https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/0001104659-18-054173-index.htm
2018-08-28Michael B HoffmanDirectorSell20,000.000.448,890.005,791,116.00https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/0001104659-18-054173-index.htm
2018-08-27Michael B HoffmanDirectorSell20,000.000.459,070.005,811,116.00https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/0001104659-18-054173-index.htm
2019-09-18683 Capital Management, LLCInsiderSell173,332.002.18377,447.76581,533.00https://www.sec.gov/Archives/edgar/data/1130598/000156761919018586/0001567619-19-018586-index.htm
2019-09-24CAPITAL PARTNERS L P TYNDALL10% Share HolderSell16,700.001.1919,873.00616,389.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000789/0000905718-19-000789-index.htm
2019-09-23CAPITAL PARTNERS L P TYNDALL10% Share HolderSell37,242.001.2345,967.80633,089.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000785/0000905718-19-000785-index.htm
2019-09-20CAPITAL PARTNERS L P TYNDALL10% Share HolderSell75,119.001.62121,429.86670,331.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000785/0000905718-19-000785-index.htm
2019-09-18CAPITAL PARTNERS L P TYNDALL10% Share HolderSell49,995.002.10105,014.50745,450.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000781/0000905718-19-000781-index.htm
2019-11-25ABRAHAM N. OLERVP Corp Dev & Gen CounselBuy75,000.000.2015,000.0075,000.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019012054/0001179110-19-012054-index.htm
2019-09-18683 Capital Management, LLCInsiderSell93,286.001.86173,138.82754,865.00https://www.sec.gov/Archives/edgar/data/1130598/000156761919018586/0001567619-19-018586-index.htm
2019-09-11CAPITAL PARTNERS L P TYNDALL10% Share HolderSell1,247.002.753,432.49795,445.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000775/0000905718-19-000775-index.htm
2019-09-09CAPITAL PARTNERS L P TYNDALL10% Share HolderSell400.002.771,106.00796,692.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000773/0000905718-19-000773-index.htm
2019-09-06CAPITAL PARTNERS L P TYNDALL10% Share HolderSell5,015.002.7813,954.24797,092.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000753/0000905718-19-000753-index.htm
2019-09-05CAPITAL PARTNERS L P TYNDALL10% Share HolderSell400.002.751,100.00802,107.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000753/0000905718-19-000753-index.htm
2019-07-10CAPITAL PARTNERS L P TYNDALL10% Share HolderSell2,742.002.817,696.79802,507.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000596/0000905718-19-000596-index.htm
2019-07-09CAPITAL PARTNERS L P TYNDALL10% Share HolderSell8,185.002.8423,204.48805,249.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000596/0000905718-19-000596-index.htm
2019-06-27CAPITAL PARTNERS L P TYNDALL10% Share HolderSell1,458.003.455,025.00813,434.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000579/0000905718-19-000579-index.htm
2019-06-25CAPITAL PARTNERS L P TYNDALL10% Share HolderSell1,380.003.404,688.69814,892.00https://www.sec.gov/Archives/edgar/data/1130598/000090571819000557/0000905718-19-000557-index.htm
2019-09-23ARMISTICE CAPITAL, LLC10% Share HolderSell0.00816,702.00https://www.sec.gov/Archives/edgar/data/1130598/000091957419006024/0000919574-19-006024-index.htm
2019-09-23ARMISTICE CAPITAL, LLC10% Share HolderSell10,249.001.2713,016.23816,702.00https://www.sec.gov/Archives/edgar/data/1130598/000091957419006024/0000919574-19-006024-index.htm
2019-09-18683 Capital Management, LLCInsiderSell118,726.002.18258,537.74848,151.00https://www.sec.gov/Archives/edgar/data/1130598/000156761919018586/0001567619-19-018586-index.htm
2019-11-25Mark Patrick GuerinChief Financial OfficerBuy87,500.000.2017,500.0087,844.00https://www.sec.gov/Archives/edgar/data/1130598/000117911019012056/0001179110-19-012056-index.htm
2020-05-19ABRAHAM N. OLERSVP Corp Dev & Gen CounselBuy15,000.000.375,550.0090,000.00https://www.sec.gov/Archives/edgar/data/1130598/000117911020006359/0001179110-20-006359-index.htm